Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients ; day:22 ; month:4 ; year:2022 ; pages:1-11
European journal of nuclear medicine and molecular imaging ; (22.4.2022), 1-11
- Creator
-
Sundlöv, Anna
Gleisner, Katarina Sjögreen
Tennvall, Jan
Ljungberg, Michael
Warfvinge, Carl Fredrik
Holgersson, Kajsa
Hallqvist, Andreas
Bernhardt, Peter
Svensson, Johanna
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-022-05786-w
- URN
-
urn:nbn:de:101:1-2022070519155484220438
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sundlöv, Anna
- Gleisner, Katarina Sjögreen
- Tennvall, Jan
- Ljungberg, Michael
- Warfvinge, Carl Fredrik
- Holgersson, Kajsa
- Hallqvist, Andreas
- Bernhardt, Peter
- Svensson, Johanna
- SpringerLink (Online service)
Other Objects (12)
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts